Primary Site >> Esophagus Cancer

Gene >> IL4

  • 2002
  • 2004
  • 2007
  • 2009
  • 2012
  • 2014
  • 2015
Ref: Neoadjuvant treatment of esophageal cancer: Immunosuppression following combined radiochemotherapy.
PMID: 12324764
 Ref: [The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer].
PMID: 15553672
 Ref: [Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
PMID: 17298741
 Ref: [Expression of transcription factor T-bet and GATA-3 in peripheral blood mononuclear cells and its correlation with immune status in esophageal cancer patients].
PMID: 19615257
Ref: C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
PMID: 19801321
 Ref: Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma.
PMID: 22200763
 Ref: Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer.
PMID: 25144454
 Ref: Effects of epidural anesthesia and postoperative epidural analgesia on immune function in esophageal carcinoma patients undergoing thoracic surgery.
PMID: 25469293
Ref: Effect of miR-503 Down-Regulation on Growth and Invasion of Esophagus Carcinoma and Related Immune Function.
PMID: 26580839